David Reznik, MD | |
2250 Chapel Ave W, Suite 100, Cherry Hill, NJ 08002-2051 | |
(856) 482-9000 | |
(856) 482-1159 |
Full Name | David Reznik |
---|---|
Gender | Male |
Speciality | Psychiatry & Neurology - Psychiatry |
Location | 2250 Chapel Ave W, Cherry Hill, New Jersey |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1235315797 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2084P0800X | Psychiatry & Neurology - Psychiatry | 25MA08629300 (New Jersey) | Primary |
Entity Name | State Of New Jersey Omb Centralized Payroll |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1467552240 PECOS PAC ID: 6406742592 Enrollment ID: O20050603000317 |
News Archive
Whereas US and European medical centers are still beginners in breast augmentation with stem cell-enriched autologous fat, Viennese New Cosmetic Surgery and anti-aging expert DDr. Karl-Georg Heinrich is well-versed in this revolutionary method. In his Clinic DDr. Heinrich, he has been successfully offering breast augmentations with autologous stem cells to a broad public since early 2007.
Research is trying to determine whether Alzheimer's disease might be slowed or prevented with nutritional approaches, but a new study suggests those efforts could be improved by use of nutrient "biomarkers" to objectively assess the nutrient status of elderly people at risk for dementia.
A large-scale survey of African-American men and women found that those who rarely or never exercised had about twice the odds of abusing alcohol than those who exercised frequently, a finding that could have implications across all groups.
Researchers from VTT Technical Research Centre of Finland have in collaboration with the University of Turku, Indiana University and two Finnish companies, Biotie Therapies Corp. and Pharmatest Services Ltd, discovered a novel mechanism regulating the development of breast cancer bone metastases and showed that heparin-like compounds can potentially be used to inhibit breast cancer metastasis to bone.
The Miriam Hospital is actively recruiting local participants for a U.S. clinical trial of the Parachute device for treating heart failure. The study is focused on determining if the new minimally invasive catheter-based device can slow the progression of heart failure, reduce repeat hospitalizations and death, and significantly improve quality of life for patients who experience enlargement of the left ventricle after a heart attack.
› Verified 8 days ago
Mailing Address | Practice Location Address |
---|---|
David Reznik, MD 2250 Chapel Ave W, Suite 100, Cherry Hill, NJ 08002-2051 Ph: (856) 482-9000 | David Reznik, MD 2250 Chapel Ave W, Suite 100, Cherry Hill, NJ 08002-2051 Ph: (856) 482-9000 |
News Archive
Whereas US and European medical centers are still beginners in breast augmentation with stem cell-enriched autologous fat, Viennese New Cosmetic Surgery and anti-aging expert DDr. Karl-Georg Heinrich is well-versed in this revolutionary method. In his Clinic DDr. Heinrich, he has been successfully offering breast augmentations with autologous stem cells to a broad public since early 2007.
Research is trying to determine whether Alzheimer's disease might be slowed or prevented with nutritional approaches, but a new study suggests those efforts could be improved by use of nutrient "biomarkers" to objectively assess the nutrient status of elderly people at risk for dementia.
A large-scale survey of African-American men and women found that those who rarely or never exercised had about twice the odds of abusing alcohol than those who exercised frequently, a finding that could have implications across all groups.
Researchers from VTT Technical Research Centre of Finland have in collaboration with the University of Turku, Indiana University and two Finnish companies, Biotie Therapies Corp. and Pharmatest Services Ltd, discovered a novel mechanism regulating the development of breast cancer bone metastases and showed that heparin-like compounds can potentially be used to inhibit breast cancer metastasis to bone.
The Miriam Hospital is actively recruiting local participants for a U.S. clinical trial of the Parachute device for treating heart failure. The study is focused on determining if the new minimally invasive catheter-based device can slow the progression of heart failure, reduce repeat hospitalizations and death, and significantly improve quality of life for patients who experience enlargement of the left ventricle after a heart attack.
› Verified 8 days ago
Thomas O'reilly, Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 2250 Chapel Ave W, Suite 100, Cherry Hill, NJ 08002 Phone: 856-482-9000 Fax: 856-482-1159 | |
Dr. Badal D Rana, D.O Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 2250 Chapel Ave W, Cherry Hill, NJ 08002 Phone: 856-482-9000 | |
Dr. Harry Madison, D.O. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 2250 Chapel Ave W, Suite 100, Cherry Hill, NJ 08002 Phone: 856-482-9000 Fax: 856-482-1159 | |
Allen C Zechowy, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 63 Kresson Road, Suite 101, Cherry Hill, NJ 08034 Phone: 856-795-2000 Fax: 856-795-3625 | |
Dr. Perry Howard Zand, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 2201 Chapel Avenue West, Suite 104, Cherry Hill, NJ 08002 Phone: 856-662-1122 Fax: 856-429-4212 | |
Hatice Burakgazi Yilmaz, MD, MS Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 2250 Chapel Ave W, Suite 100, Cherry Hill, NJ 08002 Phone: 856-482-9000 Fax: 856-482-1159 | |
Gino Grosso, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 1930 Marlton Pike E, Suite G-38, Cherry Hill, NJ 08003 Phone: 856-751-7280 Fax: 856-751-7209 |